ORTEXORTEX News
Tracking VALE? Get live short interest, options flow, and signals on ORTEX.Sign up free →
VA
Earnings PreviewVALE

Vale Shorts Retreat as Shares Hit New Lows

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 30 Oct 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Vale S.A. has shed 17.7% over the past month, closing at $11.18 on October 29, its lowest level in the recent period. Short sellers who drove the build from roughly 43 million shares in mid-September to a peak near 61 million in mid-October have since pulled back sharply. Estimated short interest dropped 13.3% over the past week to 51.1 million shares, unwinding a significant portion of the Q3 build. The borrow market tells the same story. Availability, already loose throughout October, has widened further to essentially uncapped levels, with more than 1.3 billion shares available to lend against the current short position. Cost to borrow remains negligible at 0.50%, up just 3% on the week. There is no mechanical pressure on existing short positions.

Options traders have shifted less dramatically than short sellers. The put/call ratio of 1.01 is actually running below its 20-day average of 1.03, by about 1.5 standard deviations, meaning the options market is modestly less defensive than it has been through October. The 52-week range runs from 0.66 to 1.23, placing current positioning toward the neutral middle. Short sellers are trimming. Options traders are calm. Neither camp is showing the kind of conviction that preceded recent moves.

The analyst community remains divided, and the gap between consensus and current price is wide. The mean price target of $16.18 implies roughly 45% upside from Thursday's close, yet several desks trimmed targets in the run-up. UBS cut to $14.50 on October 21 while staying Neutral, and Barclays reduced its target to $15 earlier in the month. JP Morgan held at Overweight with a $22 target, the most bullish name on the desk by a distance. Scotiabank upgraded to Sector Outperform on October 19. The bull case rests on the base metals franchise, copper project IRRs in the 24.9% to 33.0% range, and a valuation that looks compressed: the forward PE has fallen to 6.1 and EV/EBITDA to 4.0 over the past 30 days. The bear case is familiar: iron ore still anchors earnings, China's seaborne exposure runs at 70% to 75% of the market, and the Simandou supply addition looms with no near-term catalyst from the Vale Base Metals IPO, which may not occur before 2028.

Capital Research and Management added 32.7 million shares in the most recent reporting period, lifting its stake to 5.35% of shares. BlackRock also added, filing a 13G/A in April that raised its disclosed stake to 6.8% from 5.3%, and now holds 6.99% on an institutional basis. Both moves represent meaningful accumulation from large passive and active managers into a stock that has lost nearly a fifth of its value over the past month. Neither constitutes an activist position: no 13D filer is on the register, and all 13D/G stakes are as last disclosed around the 5% threshold.

The Q3 print, due today, will test whether iron ore realised prices and production volumes held up well enough to defend the valuation case that optimists have been building as the shares declined.

Stocks in this article

See the live data behind this article on ORTEX.

Open VALE on ORTEX →

How this article was generated

Generated
30 Oct 2026, 04:05
Data as of
30 Oct 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.